Dwayne Crabtree, MD | |
1000 W 10th St., Dept. Of Pathology, Rolla, MO 65401 | |
(573) 458-7053 | |
(573) 458-8400 |
Full Name | Dwayne Crabtree |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 29 Years |
Location | 1000 W 10th St., Rolla, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316033038 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 2002015962 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Phelps County Regional Medical Center | Rolla, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Laboratory Services Inc | 3476570615 | 2 |
News Archive
A new study suggests that genes may not be to blame for the increased risk of heart disease some studies have shown in people with migraine, especially those with migraine with aura. The research is published during Headache/Migraine Awareness Month in the inaugural issue of the journal Neurology Genetics, an open access, or free to the public, online-only, peer-reviewed journal from the American Academy of Neurology.
Two products from Prescient Medical - the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System - will be featured at the 3rd Annual Canaccord Adams Cardiovascular Conference. The conference will take place on Tuesday, November 10th in San Francisco, California, and will bring together a select group of med-tech and biotech companies focused on the most important markets in cardiovascular medicine.
With equipment designed to probe the smallest segments of the genetic code, researchers at Dana-Farber Cancer Institute and collaborating institutions have found sections of the chromosomes of lung cancer cells where cancer-related genes may lurk.
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 1 days ago
Entity Name | Medical Laboratory Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538373899 PECOS PAC ID: 3476570615 Enrollment ID: O20091130000093 |
News Archive
A new study suggests that genes may not be to blame for the increased risk of heart disease some studies have shown in people with migraine, especially those with migraine with aura. The research is published during Headache/Migraine Awareness Month in the inaugural issue of the journal Neurology Genetics, an open access, or free to the public, online-only, peer-reviewed journal from the American Academy of Neurology.
Two products from Prescient Medical - the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System - will be featured at the 3rd Annual Canaccord Adams Cardiovascular Conference. The conference will take place on Tuesday, November 10th in San Francisco, California, and will bring together a select group of med-tech and biotech companies focused on the most important markets in cardiovascular medicine.
With equipment designed to probe the smallest segments of the genetic code, researchers at Dana-Farber Cancer Institute and collaborating institutions have found sections of the chromosomes of lung cancer cells where cancer-related genes may lurk.
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dwayne Crabtree, MD 1000 W 10th St., Dept. Of Pathology, Rolla, MO 65401 Ph: (573) 458-7053 | Dwayne Crabtree, MD 1000 W 10th St., Dept. Of Pathology, Rolla, MO 65401 Ph: (573) 458-7053 |
News Archive
A new study suggests that genes may not be to blame for the increased risk of heart disease some studies have shown in people with migraine, especially those with migraine with aura. The research is published during Headache/Migraine Awareness Month in the inaugural issue of the journal Neurology Genetics, an open access, or free to the public, online-only, peer-reviewed journal from the American Academy of Neurology.
Two products from Prescient Medical - the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System - will be featured at the 3rd Annual Canaccord Adams Cardiovascular Conference. The conference will take place on Tuesday, November 10th in San Francisco, California, and will bring together a select group of med-tech and biotech companies focused on the most important markets in cardiovascular medicine.
With equipment designed to probe the smallest segments of the genetic code, researchers at Dana-Farber Cancer Institute and collaborating institutions have found sections of the chromosomes of lung cancer cells where cancer-related genes may lurk.
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 1 days ago
Dr. Paul D Cook, D.O. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1000 W 10th St, Dept. Of Pathlogy, Rolla, MO 65401 Phone: 573-458-7057 |